Request Free Sample ×
Surgical Stents Market Research Report - Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Surgical Stents Market

ID: MRFR/MED/0538-HCR
200 Pages
Nidhi Mandole, Rahul Gotadki
Last Updated: May 15, 2026

Surgical Stents Market Research Report By Product Type (Coronary Stents, Peripheral Stents, Biliary Stents, Urological Stents, Gastrointestinal Stents), By Material (Metal Stents, Polymer Stents, Bioabsorbable Stents, Coated Stents), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Delivery Method (Balloon-Expandable Stents, Self-Expanding Stents), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Surgical Stents Market Infographic
Summary Table of Contents Segmentation Methodology Download PDF

Surgical Stents Market Summary

As per Market Research Future analysis, the Surgical Stents Market Size was estimated at 6.07 USD Billion in 2024. The Surgical Stents industry is projected to grow from 6.363 USD Billion in 2025 to 10.2 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.83% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Surgical Stents Market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • Technological advancements are enhancing the efficacy and safety of surgical stents, particularly in North America.
  • The rising demand for minimally invasive procedures is propelling the adoption of urological stents, which are currently the fastest-growing segment.
  • Coronary stents remain the largest segment, reflecting the high prevalence of cardiovascular diseases in the region.
  • Key market drivers include the increasing prevalence of cardiovascular diseases and technological innovations in stent design, which are shaping the market landscape.

Market Size & Forecast

2024 Market Size 6.07 (USD Billion)
2035 Market Size 10.2 (USD Billion)
CAGR (2025 - 2035) 4.83%

Major Players

Abbott (US), Boston Scientific (US), Medtronic (IE), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Stryker Corporation (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Surgical Stents Market Trends

The Surgical Stents Market is currently experiencing a notable evolution, driven by advancements in technology and increasing demand for minimally invasive procedures. Innovations in materials and design are enhancing the efficacy and safety of stents, which are crucial in various surgical applications. As healthcare providers seek to improve patient outcomes, the focus on biocompatible materials and drug-eluting stents is becoming more pronounced. This shift not only addresses the need for better performance but also aligns with the growing emphasis on personalized medicine, where treatments are tailored to individual patient needs. Moreover, The Surgical Stents Market is influenced by an aging population and rising prevalence of chronic diseases. These factors contribute to a higher incidence of conditions requiring stenting procedures, such as cardiovascular diseases and urinary tract disorders. The market appears poised for growth as healthcare systems adapt to these demographic changes and invest in advanced surgical technologies. Additionally, regulatory bodies are increasingly supporting innovation, which may further facilitate the introduction of new products into the market. Overall, the Surgical Stents Market is on a trajectory of expansion, characterized by continuous improvement and adaptation to emerging healthcare challenges.

Technological Advancements

The Surgical Stents Market is witnessing rapid technological advancements that enhance the performance and safety of stents. Innovations in materials, such as bioresorbable stents, are gaining traction, offering potential benefits over traditional options. These developments may lead to improved patient outcomes and reduced complications.

Rising Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive surgical techniques within the Surgical Stents Market. This trend is driven by the desire for shorter recovery times and reduced hospital stays. As healthcare providers increasingly adopt these techniques, the demand for stents that facilitate such procedures is likely to rise.

Focus on Personalized Medicine

The Surgical Stents Market is gradually shifting towards personalized medicine, where treatments are tailored to individual patient profiles. This approach may enhance the effectiveness of stenting procedures, as healthcare providers seek to optimize outcomes based on specific patient characteristics and needs.

Surgical Stents Market Drivers

Rising Geriatric Population

The increasing geriatric population is a significant factor driving the Surgical Stents Market. As individuals age, they are more susceptible to various health conditions, including cardiovascular diseases, which often require surgical intervention. The World Health Organization projects that the number of people aged 60 years and older will double by 2050, leading to a higher demand for surgical stents. This demographic shift necessitates the development of specialized stenting solutions tailored to the unique needs of older patients. Consequently, the Surgical Stents Market is likely to experience robust growth as healthcare providers focus on addressing the challenges posed by an aging population.

Technological Innovations in Stent Design

Technological advancements in stent design and materials are significantly influencing the Surgical Stents Market. Innovations such as drug-eluting stents and bioresorbable stents are enhancing the efficacy and safety of procedures. These advancements not only improve patient outcomes but also reduce the risk of complications associated with traditional stents. The introduction of new materials, such as polymers and metals, has led to stents that are more durable and biocompatible. As a result, healthcare providers are increasingly adopting these advanced stents, contributing to market growth. The Surgical Stents Market is poised for further expansion as ongoing research and development efforts yield even more sophisticated stent technologies.

Regulatory Support and Reimbursement Policies

Supportive regulatory frameworks and favorable reimbursement policies are crucial drivers of the Surgical Stents Market. Governments and health authorities are increasingly recognizing the importance of stenting procedures in managing cardiovascular diseases, leading to streamlined approval processes for new stent technologies. Furthermore, reimbursement policies that cover the costs of stenting procedures encourage healthcare providers to adopt these interventions. This regulatory environment fosters innovation and investment in the Surgical Stents Market, as companies are motivated to develop new products that meet regulatory standards and address patient needs. As a result, the market is likely to see continued growth in the coming years.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases is a primary driver for the Surgical Stents Market. As populations age and lifestyle-related health issues become more prevalent, the demand for effective treatment options escalates. According to recent data, cardiovascular diseases account for a substantial percentage of global mortality rates, necessitating the use of surgical stents for interventions such as angioplasty. This trend indicates a growing market for stents, as healthcare providers seek to address the needs of patients with coronary artery disease and other related conditions. The Surgical Stents Market is likely to expand as healthcare systems adapt to these challenges, investing in advanced stenting technologies to improve patient outcomes.

Growing Awareness and Accessibility of Healthcare

Increased awareness of health issues and improved access to healthcare services are propelling the Surgical Stents Market. As patients become more informed about treatment options for cardiovascular diseases, the demand for surgical stents rises. Additionally, advancements in healthcare infrastructure and insurance coverage are making these procedures more accessible to a broader population. This trend is particularly evident in emerging markets, where healthcare systems are evolving to meet the needs of their citizens. The Surgical Stents Market is expected to benefit from this growing awareness and accessibility, as more patients seek timely interventions for their health concerns.

Market Segment Insights

By Type: Coronary Stents (Largest) vs. Urological Stents (Fastest-Growing)

The Surgical Stents Market showcases significant diversity across various types. Coronary Stents hold the largest market share, primarily due to their widespread use in treating coronary artery disease. In contrast, Peripheral Stents and Biliary Stents follow closely, capturing substantial market segments through their respective applications in vascular and biliary tract interventions. Meanwhile, Urological and Gastrointestinal Stents are increasingly gaining traction, reflecting an evolving therapeutic landscape driven by patient needs and technological advancements. Growth trends within the Surgical Stents Market highlight a robust shift towards minimally invasive procedures. Urological Stents are emerging as the fastest-growing segment due to rising incidences of renal problems and advances in stent technologies that enhance patient outcomes. This surge is further influenced by an aging population and increasing awareness of preventative surgical interventions, creating a dynamic interplay of demand across various stent types.

Coronary Stents (Dominant) vs. Urological Stents (Emerging)

Coronary Stents represent the dominant segment in the Surgical Stents Market, widely recognized for their critical role in cardiovascular treatments. They are designed to keep coronary arteries open, preventing blockages and ensuring efficient blood flow. Innovations in material science and the introduction of bioresorbable stents have significantly enhanced their appeal, leading to improved patient outcomes. On the other hand, Urological Stents are considered an emerging segment, gaining prominence due to increasing prevalence of urological disorders. These stents facilitate urine flow from the kidneys to the bladder and are crucial in various surgical procedures. Their design has evolved to accommodate patient comfort and reduce the risk of infections, alignment with growing health standards and technology advancements.

By Material: Metal Stents (Largest) vs. Bioabsorbable Stents (Fastest-Growing)

In the Surgical Stents Market, the material segment exhibits a diverse composition where Metal Stents hold the largest market share, appreciated for their durability and effectiveness. Conversely, Polymer Stents and Coated Stents also contribute significant portions but are overshadowed by their metallic counterparts. Bioabsorbable Stents are emerging as a key player, increasingly appealing to both healthcare professionals and patients due to their temporary nature and reduced risk of complications associated with permanent stenting solutions. The growth trends within the material segment are largely driven by advancements in technology and increasing patient preferences. The demand for less permanent solutions is propelling Bioabsorbable Stents to rise rapidly, as they provide the requisite support during healing and then dissolve over time. Innovations in polymer formulations and coating techniques are also fostering growth within Polymer and Coated Stents, ensuring these materials meet the evolving needs of the Surgical Stents Market.

Metal Stents (Dominant) vs. Polymer Stents (Emerging)

Metal Stents have established themselves as the dominant choice in the Surgical Stents Market due to their robust design and long-standing history of effectiveness in various applications. Their traditional use in treating coronary and peripheral artery diseases has solidified their position, with features such as radial strength and biocompatibility. Meanwhile, Polymer Stents are emerging as a strong competitor, driven by continuous research and innovations aimed at improving patient outcomes. These stents offer flexibility and customization, allowing for tailored treatments while ensuring compatibility with the human body. As healthcare providers seek to balance cost and clinical efficiency, both Metal and Polymer Stents play crucial roles in shaping future treatment protocols.

By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Surgical Stents Market, hospitals represent the largest end-user segment, capturing a substantial share of the overall market. Their extensive facilities and comprehensive surgical departments enable them to handle a wide array of stenting procedures. Ambulatory Surgical Centers (ASCs), while smaller in market share, are witnessing rapid growth thanks to their efficient surgical services and increasing patient preference for outpatient procedures. Specialty clinics, although significant, occupy a smaller portion of the market as they cater to niche patient needs.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

Hospitals stand as the dominant players in the Surgical Stents Market, equipped with advanced technology and a broad spectrum of services. Their ability to manage complex surgical cases and provide personalized patient care positions them favorably against smaller establishments. Specialty clinics, emerging as vital contenders, focus on particular medical fields like cardiology or urology, offering specialized stenting services. Their targeted approach allows for high-quality care, yet they face challenges in competing with the extensive resources and multi-disciplinary teams available at hospitals, meaning they cater to a more defined patient base.

By Delivery Method: Balloon-Expandable Stents (Largest) vs. Self-Expanding Stents (Fastest-Growing)

In the Surgical Stents Market, Balloon-Expandable Stents hold a considerable share due to their established efficacy in various vascular procedures. They have been widely adopted for their reliability in delivering therapeutic agents and expanding the blocked arteries, contributing significantly to their market dominance. Conversely, Self-Expanding Stents, although smaller in market share, are gaining traction as innovators develop materials and designs that enhance their usability and effectiveness in diverse clinical scenarios. The growth trends in this segment highlight an increasing preference for minimally invasive procedures, driving demand for both types of stents. Advancements in technology, such as biocompatible materials in Self-Expanding Stents, are enhancing performance and patient outcomes. Additionally, awareness of the benefits of timely stenting procedures in disease management continues to stimulate market growth, especially for the self-expanding technology, which appeals to physicians seeking flexible solutions for complex cases.

Delivery Methods: Balloon-Expandable (Dominant) vs. Self-Expanding (Emerging)

Balloon-Expandable Stents are characterized by their deliverability and adaptability during surgical procedures. These stents utilize an inflatable balloon to expand, making them suitable for arteries with significant lesions. Their dominance in the market stems from their proven track record in various clinical settings, making them a preferred choice for many surgeons. In contrast, Self-Expanding Stents are designed with unique characteristics that allow them to expand on their own after being deployed, making them particularly effective in treating areas with irregular anatomy. This technology is emerging quickly, with ongoing research into their applications driving innovation, making them a vital option in complex vascular interventions and cardiac procedures.

Get more detailed insights about Surgical Stents Market
Request Free Sample

Regional Insights

The Surgical Stents Market presented a diverse landscape across its regional segmentation. North America dominated the market with a valuation of 2.5 USD Billion in 2024 and is expected to reach 4.1 USD Billion by 2035, largely due to its advanced healthcare infrastructure and high adoption of innovative medical technologies.Europe followed, with a valuation of 1.8 USD Billion in 2024, growing to 2.9 USD Billion by 2035, driven by increasing cardiovascular disease prevalence and regulatory support for medical devices.

Asia Pacific held a notable position, also valued at 1.8 USD Billion in 2024 and anticipated to match Europe by 2035, reflecting rapid urbanization and an increasing geriatric population.

South America was valued at 0.5 USD Billion in 2024, growing to 0.8 USD Billion by 2035, indicating a moderate yet emerging market driven by improved healthcare access. The Middle East and Africa, although valued at 0.47 USD Billion in 2024, showed potential for growth, with an increase to 0.6 USD Billion in 2035, as healthcare investments rose in response to growing health concerns.These insights underlined the varied growth trajectories within the Surgical Stents Market and highlighted North America as a major player while pointing to significant opportunities in emerging markets.

Surgical Stents Market Regional Image

Key Players and Competitive Insights

The Surgical Stents Market is characterized by a diverse range of stakeholders, including multinational corporations, regional players, and niche innovators. The competition in this market is intensified by the continuous advancements in technology, along with the rising demand for minimally invasive surgical procedures globally. Companies in this sector are constantly working on developing innovative solutions to enhance patient outcomes and reduce recovery times. This dynamic nature of the market has led to strategic partnerships, mergers, and collaborations as players strive to maintain their competitive edge and expand their market share. Regulatory approvals and clinical outcomes also play a critical role in shaping the competitive landscape, as they influence not only product offerings but also market entry strategies for new entrants.MicroPort Scientific stands out in the Surgical Stents Market due to its strong focus on innovation and quality. The company has developed a robust portfolio of surgical stents that address various medical needs, showcasing its commitment to improving patient care and outcomes. MicroPort Scientific has made strategic investments in research and development, empowering it to introduce cutting-edge technologies that enhance the functionality and effectiveness of stents. The company is also known for its strong distribution network globally, allowing it to reach various healthcare providers and patients efficiently. This extensive market presence is complemented by a reputation for high-quality manufacturing standards, which bolsters customer confidence and brand loyalty within the competitive landscape.Stentys has carved out a significant niche in the Surgical Stents Market with its focus on innovative solutions targeted primarily at cardiovascular conditions. The company is recognized for its specialized stent offerings, including self-expanding stents that address the unique challenges faced during percutaneous coronary interventions. With a presence in numerous international markets, Stentys has established partnerships with leading hospitals and healthcare systems to support enhanced patient care. The company's strengths lie in its commitment to research and development, which has led to patented technologies that differentiate its products from competitors.Stentys has also engaged in strategic mergers and acquisitions to bolster its product portfolio and enhance its global reach, ensuring that it remains competitive and well-positioned amidst the evolving demands of the surgical stent market.

Key Companies in the Surgical Stents Market include

Industry Developments

By paying €760 million to acquire Biotronik's Vascular Intervention division in July 2025, Teleflex greatly increased the scope of its active treatment offering by adding a variety of interventional access solutions.A significant advancement in bioresorbable stent technology, which supports vascular healing before progressively dissolving, was made in June 2025 when StentIt reported the first-in-human implantation of their Resorbable Fibrillated Scaffold (RFS) in patients with persistent limb-threatening ischemia below the knee.

Abbott's next-generation XIENCE Sierra drug-eluting coronary stent system, which integrates AI-enabled imaging tools and improves deliverability and accuracy for difficult coronary treatments, was introduced in India in May 2024.For its Advanix biliary plastic stents, which provide improved deliverability and repositionability for the treatment of biliary strictures and cancers, Boston Scientific obtained FDA 510(k) clearance and CE Mark certification in October 2024.

The first patient implantation in a study intended to support a future FDA filing took place at Brigham and Women's Hospital in 2024 when Microbot Medical launched its key IDE clinical trial with the LIBERTY® endovascular robotic surgical system.The company's foray into low-profile covered stent solutions began in 2023 when Endovastec announced the first clinical implantations of their Castor branching aortic stent-graft and Hercules‑LP thoracic stent graft in Singapore.

Future Outlook

Surgical Stents Market Future Outlook

The Surgical Stents Market is projected to grow at a 4.83% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of biodegradable stents for enhanced patient outcomes. Expansion into emerging markets with tailored product offerings. Integration of AI for personalized stent design and patient monitoring.

By 2035, the Surgical Stents Market is expected to achieve substantial growth and innovation.

Market Segmentation

Surgical Stents Market Type Outlook

  • Coronary Stents
  • Peripheral Stents
  • Biliary Stents
  • Urological Stents
  • Gastrointestinal Stents

Surgical Stents Market End-user Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Surgical Stents Market Material Outlook

  • Metal Stents
  • Polymer Stents
  • Bioabsorbable Stents
  • Coated Stents

Surgical Stents Market Delivery Method Outlook

  • Balloon-Expandable Stents
  • Self-Expanding Stents

Report Scope

MARKET SIZE 2024 6.07(USD Billion)
MARKET SIZE 2025 6.363(USD Billion)
MARKET SIZE 2035 10.2(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.83% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott (US), Boston Scientific (US), Medtronic (IE), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Stryker Corporation (US)
Segments Covered Product Type, Material, End-user, Delivery Method, Regional
Key Market Opportunities Advancements in biodegradable materials enhance the Surgical Stents Market's potential for patient-centered solutions.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Surgical Stents Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Surgical Stents Market by 2035?

The Surgical Stents Market is projected to reach a valuation of 10.2 USD Billion by 2035.

What was the market valuation of the Surgical Stents Market in 2024?

In 2024, the Surgical Stents Market was valued at 6.07 USD Billion.

What is the expected CAGR for the Surgical Stents Market during the forecast period 2025 - 2035?

The expected CAGR for the Surgical Stents Market during the forecast period 2025 - 2035 is 4.83%.

Which companies are considered key players in the Surgical Stents Market?

Key players in the Surgical Stents Market include Abbott, Boston Scientific, Medtronic, and Johnson & Johnson.

What are the projected valuations for different types of stents by 2035?

By 2035, the projected valuations for stent types include Coronary Stents at 4.0 USD Billion and Peripheral Stents at 2.5 USD Billion.

How do the valuations of metal and polymer stents compare in 2035?

In 2035, metal stents are projected to reach 4.0 USD Billion, while polymer stents are expected to reach 2.5 USD Billion.

What is the anticipated market size for hospitals as end-users of surgical stents by 2035?

The anticipated market size for hospitals as end-users of surgical stents is projected to be 4.1 USD Billion by 2035.

What delivery method for stents is expected to have the highest valuation by 2035?

By 2035, self-expanding stents are expected to have the highest valuation at 6.15 USD Billion.

What is the projected growth for biliary stents from 2024 to 2035?

Biliary stents are projected to grow from 0.8 USD Billion in 2024 to 1.2 USD Billion by 2035.

How does the market for specialty clinics as end-users of surgical stents look by 2035?

The market for specialty clinics as end-users of surgical stents is projected to reach 3.6 USD Billion by 2035.

Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, interventional cardiology and endovascular publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA) Medical Device Coordination Group (MDCG), National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), National Center for Biotechnology Information (NCBI/PubMed), Society for Cardiac Angiography and Interventions (SCAI), European Association for Percutaneous Cardiovascular Interventions (EAPCI), American College of Cardiology (ACC), American Heart Association (AHA), World Health Organization (WHO) Cardiovascular Disease Database, CDC National Center for Health Statistics (NCHS) Heart Disease and Stroke Statistics, OECD Health Statistics, European Society of Cardiology (ESC) Registry Data, National Cardiovascular Data Registry (NCDR) CathPCI Registry, British Cardiovascular Intervention Society (BCIS) Audit, Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and national cardiovascular registries from key markets (Germany's BQS Institute, France's HAS, Australia's NCOR). These sources were used to collect stent implantation statistics, regulatory approval data (PMA, 510(k), CE Mark), clinical safety and efficacy studies (TLR, MACE, restenosis rates), demographic trends in cardiovascular and peripheral artery disease, and competitive landscape analysis for coronary stents, peripheral vascular stents, biliary stents, urological stents, and gastrointestinal stent technologies.

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of R&D, regulatory affairs leaders, clinical affairs directors, and commercial leads from stent manufacturers, stent delivery system OEMs, and coating technology providers. Interventional cardiologists, vascular surgeons, interventional radiologists, urologists, gastroenterologists, cath lab directors, procurement managers from hospitals and academic medical centers, and administrative directors from specialty endoscopy/urology clinics and ambulatory surgical centers (ASCs) comprised demand-side sources. The primary research validated market segmentation across product types, confirmed the timelines for the next-generation stent pipeline (bioresorbable scaffolds, drug-coated balloons with provisional stenting), and obtained insights on clinical adoption patterns, pricing strategies, tender dynamics, and reimbursement pathways for drug-eluting stents (DES) vs. bare-metal stents (BMS) vs. bioresorbable vascular scaffolds (BVS).

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Product mapping across coronary stents (DES, BMS, BVS), peripheral stents (femoropopliteal, infrapopliteal, carotid, renal), biliary stents (plastic vs. metal), urological stents (ureteral, prostatic, urethral), and gastrointestinal stents (esophageal, colonic, duodenal/pancreatic)

Material segmentation analysis across metal stents (cobalt-chromium, platinum-chromium, stainless steel, nitinol), polymer stents, bioabsorbable stents (PLLA, magnesium-based), and coated stents (polymer-based drug-eluting, passive coatings)

Delivery method segmentation: Balloon-expandable stents (coronary, biliary) vs. Self-expanding stents (peripheral, carotid, TAVR)

Analysis of reported and modeled annual revenues specific to stent portfolios, including OEM supply agreements for balloon-expandable delivery systems

Coverage of manufacturers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country, stratified by stent type and clinical indication) and top-down (manufacturer revenue validation, adjusted for interventional accessories and catheter sales) approaches to derive segment-specific valuations

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓